The costs of health care: implications for anti-emetic therapy.
Health economists assess new drug innovations to improve choice. Decision-making techniques for cost analysis should include not only direct costs but costs in terms of increased health benefit, reduced mortality and improved quality of life. The use of anti-emetic drugs results in a significant improvement in the quality of life of patients and decision making on the use of anti-emetic drugs should fully evaluate this patient benefit.
Bosanquet
N
N
St Mary's Hospital Medical School/Imperial College, Department of General Practice, Lisson Grove Health Centre, London, UK.
D000553:Ambulatory Care; D000932:Antiemetics / Q000191:economics* / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D006296:Health Services / Q000191:economics*; D006801:Humans; D007902:Length of Stay
D000932:Antiemetics